Welcome to our dedicated page for Arhaus SEC filings (Ticker: ARHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Arhaus, Inc. (NASDAQ: ARHS) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as a public retailer of premium, artisan-crafted home furnishings. As an omni-channel lifestyle brand, Arhaus uses SEC filings to report its financial results, material agreements, governance changes, and other significant events.
Investors can review current reports on Form 8-K, which Arhaus uses to furnish quarterly financial results and related press releases under the Results of Operations and Financial Condition item. These filings typically include information on net revenue trends, gross margin, comparable growth metrics, showroom project activity, and management commentary on business performance. Form 8-Ks also document material definitive agreements, such as amendments to the company’s revolving credit facility with Bank of America, N.A., including changes to maturity dates, commitments, and related terms.
Additional 8-K filings may cover board and executive matters, including the appointment of new independent directors and updates to board composition or committee assignments. These disclosures provide context on the company’s governance and the experience represented on its board.
Through Stock Titan, users can follow Arhaus’ filings as they are posted to the SEC’s EDGAR system, and take advantage of AI-powered summaries that explain the key points in plain language. This includes highlights from annual and quarterly reports when available, as well as insights into liquidity, capital structure, and showroom-related investments discussed in management’s commentary.
For those researching ARHS stock, the SEC filings page serves as a primary source for understanding how Arhaus communicates its financial condition, growth initiatives, credit arrangements, and governance decisions to regulators and investors.
ADAMS ALBERT T reported acquisition or exercise transactions in this Form 4 filing.
Arhaus, Inc. director Albert T. Adams received a grant of 832 dividend equivalent rights on March 31, 2026. These rights accrued on his unvested Restricted Stock Units and will vest in step with those RSUs. Each dividend equivalent right is economically equal to one share of Arhaus Class A common stock.
Burgdoerfer Stuart B reported acquisition or exercise transactions in this Form 4 filing.
Arhaus, Inc. director Stuart B. Burgdoerfer received a grant of 832 Dividend Equivalent Rights on March 31, 2026. These rights accrued on unvested Restricted Stock Units and each right is economically equivalent to one share of Arhaus Class A common stock. The grant was recorded at a price of $0.00 per right and represents compensation tied to existing RSU awards rather than an open-market transaction.
Doody Alton F III reported acquisition or exercise transactions in this Form 4 filing.
Arhaus, Inc. director Alton F. Doody III received a grant of 832 Dividend Equivalent Rights tied to unvested Restricted Stock Units as of March 31, 2026. These rights, each economically equivalent to one share of Class A common stock, were awarded at no cost and vest proportionately with the related RSUs.
Hyde Andrea reported acquisition or exercise transactions in this Form 4 filing.
Arhaus, Inc. director Andrea Hyde received a grant of 832 dividend equivalent rights linked to unvested Restricted Stock Units outstanding on March 31, 2026. Each dividend equivalent right is economically equivalent to one share of Arhaus Class A Common Stock and will vest proportionately with the related RSUs.
DePree Alexis reported acquisition or exercise transactions in this Form 4 filing.
Arhaus, Inc. director Alexis DePree received a grant of 832 Dividend Equivalent Rights on unvested Restricted Stock Units as of March 31, 2026. These rights vest in step with the underlying RSUs, and each right is the economic equivalent of one share of Arhaus Class A Common Stock.
KYEES JOHN E reported acquisition or exercise transactions in this Form 4 filing.
Arhaus, Inc. director John E. Kyees reported receiving a grant of 832 Dividend Equivalent Rights tied to unvested Restricted Stock Units as of March 31, 2026. Each right is economically equal to one share of Class A common stock and will vest proportionately with the related RSUs.
VELTRI KATHY E reported acquisition or exercise transactions in this Form 4 filing.
Arhaus, Inc. Chief Retail Officer Kathy E. Veltri received a grant of 11,919 dividend equivalent rights tied to her existing equity awards. These rights accrued on unvested Restricted Stock Units and Performance Share Units outstanding on March 31, 2026 and will vest in step with those awards. Each dividend equivalent right is economically equivalent to one share of Arhaus Class A common stock, reflecting routine, compensation-related accruals rather than an open-market stock purchase or sale.
Arhaus, Inc. is calling a virtual-only annual stockholders meeting on May 14, 2026 at 9:00 a.m. Eastern Time to elect three directors, hold an advisory vote on named executive officer pay, and seek non-binding approval of PricewaterhouseCoopers LLP as independent accountants.
Only holders of record as of March 16, 2026 may vote. The company has 54,163,394 shares of Class A common stock and 87,115,600 shares of Class B common stock outstanding, with Class A carrying one vote per share and Class B ten votes per share. The proxy details a classified board structure, committee memberships, related-party leases, and an executive pay program combining salary, annual cash incentives and equity awards. CEO total compensation for 2025 was $4,649,751, about 83 times the $55,818 median employee pay.
Arhaus Inc: The Vanguard Group filed an amended Schedule 13G/A reporting that it beneficially owns 0 shares of Arhaus Inc. common stock, representing 0% of the class. The filing notes an internal realignment effective January 12, 2026 under SEC Release No. 34-39538, after which certain Vanguard subsidiaries will report separately.